Abietic acid inhibits acetaminophen-induced liver injury by alleviating inflammation and ferroptosis through regulating Nrf2/HO-1 axis

Int Immunopharmacol. 2023 May:118:110029. doi: 10.1016/j.intimp.2023.110029. Epub 2023 Mar 22.

Abstract

Abietic acid has been known to exhibit anti-inflammatory activity. This study was designed to investigate the protective effects of abietic acid on acetaminophen (APAP)-induced liver injury. The data demonstrated that abietic acid significantly ameliorated APAP-induced liver pathological changes, TNF-α and IL-1β production. APAP could increase malondialdehyde (MDA) and Fe2+ levels, and decrease ATP and glutathione (GSH) levels, as well as glutathione peroxidase 4 (GPX4) and xCT expression. However, these changes induced by APAP were prevented by abietic acid, indicating abietic acid could inhibit APAP-induced ferroptosis. Furthermore, abietic acid inhibited APAP-induced NF-κB activation and increased the expression of Nrf2 and HO-1. Additionally, the inhibitory effects of abietic acid on APAP-induced liver injury were prevented in Nrf2-/- mice. In vitro, the inhibition of abietic acid on APAP-induced inflammation and ferroptosis were reversed when Nrf2 was knockdown. In summary, abietic acidexhibited a therapeutic effectagainst liver injury by attenuating inflammation and ferroptosis.

Keywords: Abietic acid; Acetaminophen; Ferroptosis; Liver injury; NF-κB.

MeSH terms

  • Acetaminophen / pharmacology
  • Animals
  • Chemical and Drug Induced Liver Injury* / pathology
  • Chemical and Drug Induced Liver Injury, Chronic* / metabolism
  • Ferroptosis*
  • Glutathione / metabolism
  • Inflammation / metabolism
  • Liver / pathology
  • Mice
  • NF-E2-Related Factor 2 / metabolism
  • Oxidative Stress

Substances

  • abietic acid
  • Acetaminophen
  • Glutathione
  • NF-E2-Related Factor 2
  • Hmox1 protein, mouse